Reliance Life Sciences, a closely held company of Mukesh Ambani, would invest about Rs 1000 crore to set up four manufacturing facilities for development of blood plasma proteins.
Blood proteins, also called serum proteins, are proteins found in blood plasma. They serve as a transport molecule for lipids (fatty substances like cholesterol), hormones, vitamins and metals.
They also serve as enzymes, complement components, protease inhibitors and kininn precursors. Serum proteins play an important role in the regulation of non-cellular activity and functioning and in the immune system.
"Encouraged by the market response, we are now developing speciality plasma proteins as well as building large world-scale plasma protein manufacturing facility compliant to international standards," said KV Subramaniam, president and CEO of Reliance Life Sciences.
The first of these four facilities is expected to be operational in the second half of the year 2007.
These facilities would also conduct research and development on agronomy and tissue culture that would provide the inputs for the farmers supplying products to the Reliance retail venture.
The company has so far introduced five plasma proteins developed from its pilot facility in Mumbai. So far about Rs 1500 crore has been in this line of research undertaken by Reliance Life Sciences.
Besides, company officials said, these facilities would also conduct clinical research and contract manufacturing work for Indian and international pharmaceutical companies.